Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Accelerate Diagnostics, Inc.    AXDX

ACCELERATE DIAGNOSTICS, INC.

(AXDX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/21/2021 01/22/2021 01/25/2021 01/26/2021 01/27/2021 Date
8.51(c) 8.78(c) 12.96(c) 12(c) 14.995(c) Last
176 850 753 942 3 176 062 2 316 429 4 522 091 Volume
-1.28% +3.17% +47.61% -7.41% +24.96% Change
More quotes
Financials (USD)
Sales 2020 11,2 M - -
Net income 2020 -77,6 M - -
Net Debt 2020 70,2 M - -
P/E ratio 2020 -10,8x
Yield 2020 -
Sales 2021 22,5 M - -
Net income 2021 -74,3 M - -
Net Debt 2021 52,6 M - -
P/E ratio 2021 -12,1x
Yield 2021 -
Capitalization 855 M 855 M -
EV / Sales 2020 82,6x
EV / Sales 2021 40,4x
Nbr of Employees 275
Free-Float 59,5%
More Financials
Company
Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live... 
More about the company
Notations Surperformance© of Accelerate Diagnostics, Inc.
Trading Rating : Investor Rating : -
More Ratings
All news about ACCELERATE DIAGNOSTICS, INC.
03:51aACCELERATE DIAGNOSTICS : Files For Up to $150 Million Mixed Shelf
MT
01/13ACCELERATE DIAGNOSTICS, INC : Results of Operations and Financial Condition, Reg..
AQ
2020ACCELERATE DIAGNOSTICS, INC : Entry into a Material Definitive Agreement, Unregi..
AQ
2020ACCELERATE DIAGNOSTICS : Live at Saint Mary's Regional Health System
PU
2020ACCELERATE DIAGNOSTICS, INC : Results of Operations and Financial Condition, Fin..
AQ
2020ACCELERATE DIAGNOSTICS : Management's Discussion and Analysis of Financial Condi..
AQ
2020ACCELERATE DIAGNOSTICS, INC : Results of Operations and Financial Condition, Fin..
AQ
2020ACCELERATE DIAGNOSTICS : 3Q Earnings Snapshot
AQ
2020Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Posts Q3 Revenue $3.6M
MT
2020ACCELERATE DIAGNOSTICS, INC : Amendment or Waiver to Code of Ethics (form 8-K)
AQ
2020ACCELERATE DIAGNOSTICS : Announcing New FDA Clearance for Accelerate PhenoTest® ..
PU
2020ACCELERATE DIAGNOSTICS, INC : Other Events, Financial Statements and Exhibits (f..
AQ
2020ACCELERATE DIAGNOSTICS : Management's Discussion and Analysis of Financial Condi..
AQ
2020ACCELERATE DIAGNOSTICS : 2Q Earnings Snapshot
AQ
2020ACCELERATE DIAGNOSTICS, INC : Change in Directors or Principal Officers (form 8-..
AQ
More news
News in other languages on ACCELERATE DIAGNOSTICS, INC.

- No features available -

More news
Chart ACCELERATE DIAGNOSTICS, INC.
Duration : Period :
Accelerate Diagnostics, Inc. Technical Analysis Chart | AXDX | US00430H1023 | MarketScreener
Technical analysis trends ACCELERATE DIAGNOSTICS, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 12,33 $
Last Close Price 15,00 $
Spread / Highest target 13,4%
Spread / Average Target -17,8%
Spread / Lowest Target -46,6%
EPS Revisions
Managers and Directors
NameTitle
Jack Phillips President, Chief Executive Officer & Director
John Patience Chairman
Steven Reichling CFO, Secretary & Chief Accounting Officer
Parampal Deol SVP, Head-Research & Development
Jack W. Schuler Independent Director
Sector and Competitors